Insider trading

Period: 120 months Stock: ITGR + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

110 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

110 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

110 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

110 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
110 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
110 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

110 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
14 Mar 2019
Borowicz Anthony W SVP Strategy,Corp Dev., IR
Sold, plan not stated
$214.80K 2,500 at 85.92
12.1%
13 Mar 2019
Spence Donald J Director
Sold, plan not stated 2×
$2.36M 27,475 at 85.84
59.4%
Sold half or more
12 Mar 2019
Spence Donald J Director
Sold, plan not stated
$1.96M 23,084 at 84.90
55.2%
Sold half or more
28 Feb 2019
Gonzalez Jose Antonio President, CRM & Neuro
Sold, plan not stated
$825.92K 9,088 at 90.88
65.9%
Sold half or more
3 Dec 2018
Flanagan Joseph F EVP, Quality & Regulatory Affa
Sold, plan not stated
$1.18M 13,633 at 86.42
66.0%
Sold half or more
20 Nov 2018
BAILEY PAMELA G Director
Sold, plan not stated 2×
$479.56K 5,767 at 83.16
10.8%
7 Nov 2018
SANFORD BILL R Director
Sold, plan not stated
$995.94K 11,169 at 89.17
14.5%
10 Sep 2018
Sold, plan not stated
$143.13K 1,761 at 81.28
3.1%
7 Sep 2018
Sold, plan not stated 2×
$2.16M 26,661 at 81.07
37.9%
5 Sep 2018
SANFORD BILL R Director
Sold, plan not stated
$692.87K 8,650 at 80.10
11.6%
4 Sep 2018
Gonzalez Jose Antonio President, CRM & Neuro
Sold, plan not stated
$494.59K 6,167 at 80.20
52.9%
Sold half or more
24 Aug 2018
McEvoy Timothy G Sr. VP, Gen. Counsel & Sec.
Sold, plan not stated
$1.67M 21,667 at 76.93
40.9%
21 Aug 2018
Bolt Jennifer M President, Electrochem
Sold, plan not stated
$1.42M 19,413 at 73.11
57.6%
Sold half or more
16 Aug 2018
Friedman Jeremy EVP, COO, Interim CFO
Sold, plan not stated
$1.06M 15,151 at 70.00
87.6%
Sold half or more
14 Aug 2018
Friedman Jeremy EVP, COO, Interim CFO
Sold, plan not stated
$1.06K 15 at 70.60
0.7%
13 Aug 2018
Friedman Jeremy EVP, COO, Interim CFO
Sold, plan not stated
$106.38K 1,500 at 70.92
41.1%
7 Aug 2018
Friedman Jeremy EVP, COO, Interim CFO
Sold, plan not stated
$447.70K 6,218 at 72.00
74.3%
Sold half or more
6 Aug 2018
Friedman Jeremy EVP, COO, Interim CFO
Sold, plan not stated
$455.54K 6,326 at 72.01
43.1%
16 May 2018
Smyth Declan Pres., Advanced Surgical, Orth
Sold, plan not stated
$899.28K 13,519 at 66.52
66.6%
Sold half or more
16 May 2018
Friedman Jeremy EVP, COO
Sold, plan not stated 2×
$716.26K 10,800 at 66.32
42.4%
16 May 2018
Bolt Jennifer M President, Electrochem
Sold, plan not stated
$237.00K 3,586 at 66.09
20.1%
16 May 2018
Haire Gary J EVP & Chief Financial Officer
Sold, plan not stated
$74.16K 1,118 at 66.33
20.2%
15 May 2018
Friedman Jeremy EVP, COO
Sold, plan not stated
$145.49K 2,201 at 66.10
7.9%
11 May 2018
Smyth Declan Pres., Advanced Surgical, Orth
Sold, plan not stated
$541.29K 8,163 at 66.31
54.7%
Sold half or more
10 May 2018
McEvoy Timothy G Sr. VP, Gen. Counsel & Sec.
Sold, plan not stated
$99.68K 1,500 at 66.45
4.6%
9 May 2018
Smyth Declan Pres., Advanced Surgical, Orth
Sold, plan not stated
$193.69K 2,913 at 66.49
30.1%
7 May 2018
Spencer Michael L Chief Ethics & Compliance Of
Sold, plan not stated
$6.50K 100 at 65.00
2.5%
3 Jan 2018
Friedman Jeremy EVP, COO
Sold, plan not stated
$366.44K 8,163 at 44.89
31.6%
3 Jan 2018
Dziedzic Joseph W President & CEO
Sold, plan not stated
$142.84K 3,182 at 44.89
13.0%
3 Jan 2018
Smyth Declan Pres., Advanced Surgical, Orth
Sold, plan not stated
$49.92K 1,112 at 44.89
17.2%
3 Jan 2018
Flanagan Joseph F EVP, Quality & Regulatory Affa
Sold, plan not stated
$35.87K 799 at 44.89
15.8%
3 Jan 2018
Haire Gary J EVP & Chief Financial Officer
Sold, plan not stated
$32.81K 731 at 44.89
27.7%
3 Jan 2018
McEvoy Timothy G Sr. VP, Gen. Counsel & Sec.
Sold, plan not stated
$25.23K 562 at 44.89
1.8%
3 Jan 2018
Gonzalez Jose Antonio President, CRM & Neuro
Sold, plan not stated
$20.78K 463 at 44.89
5.9%
3 Jan 2018
Spencer Michael L Chief Ethics & Compliance Of
Sold, plan not stated
$13.83K 308 at 44.89
21.1%
3 Jan 2018
Bolt Jennifer M President, Electrochem
Sold, plan not stated
$9.88K 220 at 44.89
1.9%
3 Jan 2018
MAZZA THOMAS J VP, Corporate Controller
Sold, plan not stated
$3.46K 77 at 44.89
2.4%
13 Dec 2017
Friedman Jeremy EVP, COO
Sold, plan not stated
$620.76K 13,533 at 45.87
86.3%
Sold half or more
12 Dec 2017
Friedman Jeremy EVP, COO
Sold, plan not stated
$426.01K 9,259 at 46.01
81.2%
Sold half or more
11 Dec 2017
SANFORD BILL R Director
Sold, plan not stated
$906.80K 19,713 at 46.00
23.9%
11 Dec 2017
Friedman Jeremy EVP, COO
Sold, plan not stated
$90.68K 1,970 at 46.03
47.8%
8 Dec 2017
SANFORD BILL R Director
Sold, plan not stated
$41.03K 892 at 46.00
1.4%
28 Nov 2017
McEvoy Timothy G Sr. VP, Gen. Counsel & Sec.
Sold, plan not stated
$172.73K 3,500 at 49.35
10.8%
27 Nov 2017
Sold, plan not stated
$686.78K 13,996 at 49.07
25.2%
17 Nov 2017
BAILEY PAMELA G Director
Sold, plan not stated
$262.79K 5,590 at 47.01
10.9%
9 Nov 2017
MAZZA THOMAS J VP, Corporate Controller
Sold, plan not stated 2×
$1.07M 23,123 at 46.16
88.5%
Sold half or more
31 Oct 2017
Bolt Jennifer M President, Electrochem
Sold, plan not stated
$367.73K 7,626 at 48.22
40.5%
6 Sep 2017
Harris John A Interim President, C&V
Sold, plan not stated
$57.25K 1,261 at 45.40
61.1%
Sold half or more
5 Jun 2017
Bolt Jennifer M President, Electrochem
Sold, plan not stated
$148.81K 3,626 at 41.04
24.4%
13 Mar 2017
Bolt Jennifer M President, Electrochem
Sold, plan not stated
$37.55K 1,000 at 37.55
8.2%
Showing 51–100 of 110. ← Newer Page 2 of 3 Older →